CN Patent

CN118239901A — 一种氨基甲酸(r)-1-(2-氯苯基)-2-四唑-2-基乙酯的晶体

Assigned to Nhwa Pharmaceutical Corp · Expires 2024-06-25 · 2y expired

What this patent protects

本发明属于医药化学领域，具体涉及一种氨基甲酸(R)‑1‑(2‑氯苯基)‑2‑四唑‑2‑基乙酯的晶体，其制备方法和用途。本发明提供的该晶型具有良好的溶解性，并且吸湿性低，稳定性高，具有良好的药物开发应用前景。

USPTO Abstract

本发明属于医药化学领域，具体涉及一种氨基甲酸(R)‑1‑(2‑氯苯基)‑2‑四唑‑2‑基乙酯的晶体，其制备方法和用途。本发明提供的该晶型具有良好的溶解性，并且吸湿性低，稳定性高，具有良好的药物开发应用前景。

Drugs covered by this patent

Patent Metadata

Patent number
CN118239901A
Jurisdiction
CN
Classification
—
Expires
2024-06-25
Drug substance claim
No
Drug product claim
No
Assignee
Nhwa Pharmaceutical Corp
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.